Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  PI3K / Akt / mTOR >  PI3K inhibitor >  3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol

3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol

Basic information Safety Supplier Related

3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Basic information

Product Name:
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
Synonyms:
  • 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
  • 3,3,-(2,4-diaminopteridine-6,7-diyl)diphenol
  • TG100-115;TG100115;TG100 115
  • 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine
  • 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol TG100-115
  • TG100-115, >=98%
  • TG100115; TG100 115
  • CS-427
CAS:
677297-51-7
MF:
C18H14N6O2
MW:
346.34
Product Categories:
  • Inhibitors
  • Akt
  • mTOR
  • PI3K
  • APIs
Mol File:
677297-51-7.mol
More
Less

3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Chemical Properties

Boiling point:
699.6±65.0 °C(Predicted)
Density 
1.516±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL in DMSO
form 
Yellow powder solid.
pka
8.54±0.10(Predicted)
color 
Light yellow to yellow
More
Less

3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol Usage And Synthesis

Uses

TG100-115 is a potent and selective phosphoinositide 3-kinase gamma/delta (PI3Kγ/δ) inhibitor. It can provide potent cardioprotection, reduce infarct development, and preserve myocardial function.

Definition

ChEBI: 3-[2,4-diamino-7-(3-hydroxyphenyl)-6-pteridinyl]phenol is a member of pteridines.

Biological Activity

tg100-115 is an inhibitor of pi3kγ and pi3kδ with ic50 values of 83 nm and 235 nm, respectively. tg100-115 shows no obvious activity against pi3kα and pi3kβ [1].tg100-115 remarkably reduced eosinophil accumulation, balf levels of classic th2 cytokine il-13, perivascular and peribronchial leukocyte accumulations, and bronchiolar mucin accumulation in a murine model. besides, tg100-115 showed to reduce airway hyper-responsiveness (ahr) by approximately 50% in asthmatic mice. moreover, tg100-115 has been reported to reduce both smoke-and lps-induced neutrophil and lps-induced classic th1 cytokine tnfα accumulations in mice [2].

target

PI3K-γ

References

[1] doukas j1, wrasidlo w, noronha g, dneprovskaia e, fine r, weis s, hood j, demaria a, soll r, cheresh d. hosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. proc natl acad sci u s a. 2006 dec 26;103(52):19866-71.
[2] doukas j1, eide l, stebbins k, racanelli-layton a, dellamary l, martin m, dneprovskaia e, noronha g, soll r, wrasidlo w, acevedo lm, cheresh da. aerosolized phosphoinositide 3-kinase gamma/delta inhibitor tg100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. j pharmacol exp ther. 2009 mar;328(3):758-65.

3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenolSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Email
sales@trio-pharmatech.com (International market)
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com
Shanghai civi chemical technology co.,Ltd
Tel
86-21-34053660
Email
sale@labgogo.com